Search PubMedSearch

PubMed · 3310100

Second-trimester polyhydramnios: evaluation with US.

Abstract

The sonograms of 40 patients with second-trimester polyhydramnios were reviewed to determine (a) whether fetal and maternal conditions occur as often during second-trimester polyhydramnios as during third-trimester polyhydramnios, (b) the frequency of persistence of polyhydramnios into the third trimester, and (c) how sonography can help in maternal and fetal management. Second-trimester polyhydramnios often (62%) persisted into the third trimester. The frequencies of maternal (25%) and fetal (12%) conditions were similar to those previously reported for third-trimester polyhydramnios. Fetal anomalies were always identified on the sonogram that initially demonstrated polyhydramnios. Fetal outcome was excellent in the nondiabetic patient with polyhydramnios in whom no fetal abnormalities were detected on sonograms. In polyhydramnios associated with maternal diabetes mellitus, however, the pregnancy was often (71%) complicated by premature labor or macrosomia. In such patients serial sonographic follow-up is indicated.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C J Sivit, M C Hill, J W Larsen, I M Lande. 1987. Second-trimester polyhydramnios: evaluation with US.. https://doi.org/10.1148/radiology.165.2.3310100

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Comparative genomic hybridization: a comparison with molecular and cytogenetic analysis.

Comparative genomic hybridization (CGH) is a powerful technique for detecting copy number changes throughout the genome. We describe the development of a versatile image analysis program for CGH studies. Several methods for the production of metaphases which give optimum hybridization signals have also been assessed. CGH analysis was performed on DNA samples from several different and clinically relevant specimens: amniotic fluid cells trisomic for a single chromosome, lymphoblastoid cell lines with abnormalities involving single chromosome bands, malignant cell lines and biopsy material from primary ovarian carcinomas. The results were compared with those derived from G-banding, chromosome painting, and molecular genetic techniques. Our data demonstrate that CGH was able to detect a wide range of quantitative genetic alterations including duplication or deletion of single chromosome bands. CGH analysis also indicated the presence of genetic abnormalities that were not detected by other cytogenetic or molecular approaches. Moreover, our CGH methodology allowed the ready comparison of CGH results from different tumors, a process which greatly facilitated identification of shared genetic changes.

Amniotic Fluid

Mathematical models to correlate amniotic fluid index and amniotic fluid volume.

PURPOSE: To describe a predictable relationship that relates amniotic fluid index (AFI) to amniotic fluid volume (AFV) and improve the accuracy of AFI to detect true oligohydramnios. METHODS: Data from 42 parturients (group I) who underwent measurements of amniotic fluid sonographically (amniotic fluid index) as well as by dye-dilution technique was used to relate AFI to AFV. Subsequently, 22 consecutive women (group II) were used to test the accuracy of the equation to predict true oligohydramnios. RESULTS: In group II, 11 of 22 patients had true oligohydramnios and the sensitivity, specificity, positive and negative predictive values of AFI < or = 5.0 to detect a confirmed AFV < 500 mL were 0%, 91%, 0%, and 48%, respectively. These values of AFI, when used in conjunction with the equation, improved to 73%, 55%, 62%, 67%, respectively. With AFI and the equation, significantly more patients in group II with true oligohydramnios (8 of 11) could be detected than with using AFI alone (0 of 11; p = 0.002). CONCLUSION: AFI is poor predictor of true oligohydramnios. Using the mathematical model, the detection rate of oligohydramnios is significantly improved.

Amniotic Fluid

Pre-term labor: an intra-uterine inflammatory response syndrome?

Emerging concepts of sepsis suggest that the host response to an infectious stimulus results in some cases of uncontrolled release of inflammatory cytokines leading to signs of sepsis. Systemic inflammatory response syndrome (SIRS) has been suggested as a diagnosis when no etiologic organism can be found. Infection may account for up to 30% of cases of pre-term labor, and may either be clinically-evident or sub-clinical. Inflammatory cytokines can be detected in elevated concentrations in the amniotic fluid and plasma of women with pre-term labor, and human gestational tissues are potentially rich sources of inflammatory cytokines, as found in in vivo and in vitro studies. Also, maternal decidua and fetal membranes produce mRNA for inflammatory cytokines in the setting of infection-associated pre-term labor and normal term labor. Notably, anti-inflammatory cytokines, such as interleukin-10 (IL-10) do not appear to be present in substantial quantities in these pathophysiologic and physiologic conditions. Animal models indicate that pre-term labor can be stimulated by bacteria, bacterial cell wall products, and inflammatory cytokines such as IL-1 and tumor necrosis factor. These findings suggest that: (1) infectious stimuli may result in the liberation of inflammatory cytokines from gestational tissues leading inevitably to pre-term labor and delivery; (2) inhibition of this process may either be overcome or abrogated, and (3) the mechanisms regulating cytokine production in maternal and fetal tissues are disturbed. Thus, pre-term labor associated with sub-clinical infection may result in a dysregulated local inflammatory response, in which the maternal host response causes an 'intra-uterine inflammatory response syndrome' leading to pre-term labor and delivery.

Amniotic Fluid